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THE DEVELOPMENT OF A NOVEL THERAPEUTIC FOR THE TREATMENT OF 
SICKLE CELL DISEASE 
 
 
 
Cody Wynn and Brian Brennan* 
Chemistry Department, Illinois Wesleyan University 
 
 
 
Sickle Cell Disease is a genetic blood disorder caused by a point mutation in the gene which 
codes for hemoglobin in red blood cells. This mutation in the protein leads to the formation of 
long polymeric strands of hemoglobin that cause the red blood cells to misform into the 
characteristic sickled shape. These sickled red blood cells are too large to fit through capillaries 
and thus cause the problems associated with sickle cell disease such as anemia and tissue 
damage. Our approach towards developing novel therapeutics involves the production and 
screening of large libraries of small peptides which target the point mutation in an effort to 
discover ligands for the protein.  Once ligands have been identified, we can determine if their 
interactions are sufficient to prevent protein polymerization.  We will present some recent 
progress that we have made on this challenging biochemical problem. 
 
 
